As previously mentioned, serum levels of FGF21 are elevated in subjects with adverse lipid profiles, obesity, metabolic syndrome, impaired glucose tolerance, type 2 diabetes mellitus, and hypertension (47, 48). This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.